Average Co-Inventor Count = 2.73
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Precision Biologics, Inc. (10 from 29 patents)
2. International Bioimmune Systems, Inc. (3 from 3 patents)
3. Neogenix Oncology, Inc. (2 from 3 patents)
15 patents:
1. 12460013 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
2. 11572413 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
3. 11001641 - Monoclonal antibody therapy for pancreas cancer
4. 10364295 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
5. 9605077 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
6. 9592290 - Monoclonal antibody therapy for pancreas cancer
7. 9169326 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
8. 9034588 - Monoclonal antibody therapy for pancreas cancer
9. 8535667 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
10. 8470326 - Monoclonal antibody therapy for pancreas cancer
11. 7763720 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
12. 7491801 - Identification and development of specific monoclonal antibodies to squamous cell carcinoma
13. 7314622 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
14. RE39760 - Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
15. 5688657 - Monoclonal antibodies against human colon carcinoma-associated antigens